Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?
about
Novel approaches to inhibition of gastric acid secretionProton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole25 Years of Proton Pump Inhibitors: A Comprehensive Review.The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole.Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.Validation of the reflux symptom questionnaire electronic diary in partial responders to proton pump inhibitor therapy.Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito.Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitorsPrediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole.Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis.Factors influencing treatment outcome in patients with gastroesophageal reflux disease: outcome of a prospective pragmatic trial in Asian patientsTransoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice.GERD assessment including pH metry predicts a high response rate to PPI standard therapyMedical management of patients after bariatric surgery: Principles and guidelines.Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations.Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.Association between obesity and Barrett's esophagus in a Japanese population: a hospital-based, cross-sectional study.Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease.Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis.Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.The value of branded proton pump inhibitors: formulary considerations.Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully respondedUnmet Needs in the Treatment of Gastroesophageal Reflux Disease.Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux diseaseComparing the Areas of Interest in the Field of Functional Gastrointestinal Disorder and Neurogastroenterology and Motility Between the East and the West.Review article: the unmet needs in delayed-release proton-pump inhibitor therapy in 2005.Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of LifeThe daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux diseaseStructured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studiesThe Proton Pump Inhibitor Non-Responder: A Clinical ConundrumManagement of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician's Opinions.Risk factors for proton pump inhibitor refractoriness in Chinese patients with non-erosive reflux disease.Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results.Esophageal pH testing in patients refractory to proton pump inhibitor therapy.Increased TRPV1 and PAR2 mRNA expression levels are associated only with the esophageal reflux symptoms, but not with the extraesophageal reflux symptomsThe effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitorAntireflux Surgery in Korea: A Nationwide Study from 2011 to 2014.
P2860
Q24614255-3E977715-3115-4FCF-9942-08261BCC85C5Q26741015-15E7C06D-ACB0-483D-8997-0F4A07049DE2Q28070003-511C7B64-6F4F-40A6-81B3-50739985D3E2Q30420132-8B272081-51DC-462E-9348-C45E98CD0A6FQ30457058-F808E542-9BFA-4C22-B5B3-9A60AACF1DCBQ30466802-8C3C0107-3BD2-40C7-B151-775D6A9FC3ECQ31170383-BEA53D53-6F06-40B3-8115-5B44C173FC8DQ33445961-66D0896C-672E-487A-8DBC-6D6C940393DBQ33862676-997A1051-429E-4970-823C-8557D69986E9Q33898572-AD9D67CE-9D4B-4914-8DB2-93C29EE7153BQ34026230-9F7E1081-55D6-487A-A944-126D59EF3929Q34252168-709C5290-1F78-41D1-9805-C0F0D3D8B505Q34278144-DEC044D6-99BF-49E9-A73A-2FB300CA4C3AQ34549954-5D9B60C7-20B1-48B6-93B9-4EA2C67DC799Q34561483-ECC48356-B76A-4D79-914F-A6F81D64BDE3Q34869267-64119D23-BC08-4581-86A4-EE5BA88CBB19Q34978725-72C9F061-756E-424F-8AF6-13601E5C9474Q35000054-D8CE140B-8D35-4A12-A331-8C8A60ED30A1Q35026352-D0B8D429-6678-4EAC-B898-12D8D5CD891AQ35113619-AD336054-BC52-4A80-95D2-AAB1E2B194BCQ35171548-460490FB-7D32-4F85-9002-89DC280962EEQ35209935-C6D8C57E-E94A-4613-8322-D3A577A091CAQ35534109-860EFEBA-643C-4934-B06B-E1B9A84B536DQ35587530-B27C7F1D-E7AA-4490-84B8-0364E26D7430Q35834504-0EB52560-6803-4787-AF4C-66E8E784783CQ35948689-9FAA386E-3831-452B-BD5C-1199425BC5BBQ35987371-8ACCD01D-187B-4D0E-BD11-A410A4331A98Q36211729-BEE5A708-0929-43E4-953C-926C181BEFD8Q36319521-DF44DC9F-1102-42EA-8B08-454B012A6C6CQ36429167-E5ED590B-0998-4AEC-A739-A945484E8E9BQ36521933-2FD1DFE8-A6DE-4E87-96E8-63A448F4D97AQ36695802-E5C175C6-F96C-4740-ACBA-83F5436C3379Q36752080-6FF7A319-80FC-4C81-9857-8104FCE2F539Q36868713-9968C081-9F03-4A34-B9AE-FE02CEFBBA9CQ36872031-5FA27D19-7465-4A64-9C18-70EB2A65149DQ37017659-02EC85C0-F0AB-465B-AE11-B8EF40935D5DQ37114646-543AC957-5932-4161-A599-08A4EA1A7249Q37175935-6D1F2887-446B-47ED-A143-05B307D735C6Q37187264-D019D55E-5ECA-41B9-8AAF-16B8E32CC413Q37213520-1416C0E9-1FEB-4BDD-903A-36ACFC0E4492
P2860
Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Systematic review: proton-pump ...... al reflux disease--where next?
@ast
Systematic review: proton-pump ...... al reflux disease--where next?
@en
type
label
Systematic review: proton-pump ...... al reflux disease--where next?
@ast
Systematic review: proton-pump ...... al reflux disease--where next?
@en
prefLabel
Systematic review: proton-pump ...... al reflux disease--where next?
@ast
Systematic review: proton-pump ...... al reflux disease--where next?
@en
P2093
P2860
P1476
Systematic review: proton-pump ...... al reflux disease--where next?
@en
P2093
P2860
P356
10.1111/J.1365-2036.2005.02531.X
P407
P577
2005-07-01T00:00:00Z